
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results
(MENAFN- GlobeNewsWire - Nasdaq) Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand. Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP ; …